Brucellosis Vaccines Market Research, 2033
The global brucellosis vaccines market size was valued at $0.2 billion in 2023, and is projected to reach $0.4 billion by 2033, growing at a CAGR of 6.4% from 2024 to 2033. The growth of the brucellosis vaccines market is primarily driven by the increasing prevalence of brucellosis in livestock, which significantly impacts animal health and agricultural economies. Rising awareness about zoonotic diseases and the importance of animal vaccination further propels market demand. Additionally, government initiatives and support for animal health programs, advancements in vaccine development technologies, and the need for effective disease management strategies contribute to market growth.
Market Introduction and Definition
Brucellosis vaccines are crucial in controlling the spread of brucellosis, a bacterial infection caused by the genus Brucella. These vaccines aim to stimulate the immune system to recognize and combat Brucella bacteria, thereby preventing infection. Vaccination strategies typically target livestock, including cattle, sheep, and goats, which are primary reservoirs of the disease and can transmit it to humans through direct contact or consumption of contaminated animal products. The effectiveness of brucellosis vaccines depends on their ability to induce strong and long-lasting immunity while minimizing adverse reactions in the vaccinated animals. However, challenges such as vaccine stability, cost, and the need for booster doses can impact the overall success of vaccination programs.
Key Takeaways
- The brucellosis vaccines market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major brucellosis vaccines industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.
Key Market Dynamics
According to brucellosis vaccines market forecast analysis the key factors driving the growth of the market are increasing prevalence of brucellosis, government initiatives and support, advancements in vaccine technology and expansion of the livestock industry. According to the 2022 article by National Library of Medicine, the prevalence of brucellosis was detected 1.3% among individual animals and 11% among herds. The rise in incidence rates has heightened the demand for effective vaccination programs to control and eradicate the disease. Governments and agricultural bodies are investing heavily in vaccination campaigns and awareness programs, further fueling market growth. Thus, increasing prevalence of the brucellosis and favorable government initiatives is expected to drive the brucellosis vaccines market growth.
In addition according to brucellosis vaccines market analysis, the expansion of the livestock industry is a significant driver of growth in the brucellosis vaccines market. As global demand for meat, dairy products, and other animal-derived goods continues to rise, the livestock sector is experiencing rapid growth. This expansion necessitates the implementation of animal health management practices to ensure the sustainability and productivity of livestock operations. Thus, the growing in the live stock industry is expected to drive the brucellosis vaccines market size.
Number of Cattle Worldwide from 2020 to 2023
The global cattle population has shown a steady increase from 2020 to 2023. In 2020, the number of cattle worldwide was 929.56 million. This number rose to 937.49 million in 2021, marking an increase of approximately 8 million cattle. The upward trend continued in 2022, with the global cattle population reaching 940.02 million. By 2023, the number of cattle worldwide further increased to 943.74 million.
According to brucellosis vaccines market trends analysis consistent growth in the global cattle population is a significant driver for the brucellosis vaccines market. Brucellosis is a highly contagious zoonotic disease that affects cattle, leading to reproductive issues such as abortions, decreased milk production, and infertility. As the number of cattle increases, the risk of brucellosis outbreaks also rises, necessitating effective prevention and control measures. Vaccination is a critical strategy in managing brucellosis, and the expanding cattle population highlights the growing demand for brucellosis vaccines.
Market Segmentation
The brucellosis vaccines industry is segmented into type, vaccine, animal type, end user, and region. By type, the market is divided into RBS1, S19, and B19. As per vaccine, the market is divided into DNA vaccine, subunit vaccine, vector vaccine, and recombinant vaccine. By animal type, the market is divided into cattle, sheep and goat. By end user, the market is divided into veterinary hospitals and clinics, animal care centers, and other. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
North America dominated the brucellosis vaccines market share owing to substantial research and development activities in brucellosis vaccines, a strong presence of major key players, and well-established healthcare industry and growing awareness about the vaccination program. However, according to brucellosis vaccines market opportunity analysis Asia-Pacific region is expected to register significant growth in the forecast period owing to large livestock industry and favorable government initiative such as veterinary vaccination program.
- In October 2022, Biotechnology and Biological Sciences Research Council (BBSRS) provided fund of $2.5 million to UK Research and Innovation for research projects to develop intervention strategies for combating endemic and infectious diseases and improving animal health.
- According to 2022 article by U.S. Department of Agriculture (USDA) , there were about 91.9 million cattle and calves in the U.S.
- According to 2023 report by U.S. Department of Agriculture, Foreign Agricultural Services, Indian Dairy sector is increasing at significant rate with 307.5 million cattle in 2023 as compared to 306.7 million head in 2022.
- According to 2024 article by Ministry of Fisheries, Animal Husbandry & Dairying (India) , there are about 535.7 million farm animals and 851.8 million poultry in India.
Industry Trends
- According to 2023 article by the Centers for Disease Control and Prevention (CDC) , the global incidence of brucellosis was around 2.1 million.
- In December 2022, researchers at University of Florida developed a novel vaccine for use against a devastating strain of brucellosis that affects small ruminants. The vaccine has shown groundbreaking effectiveness in conferring long-term immunity in mice.
- According to 2022 report by National Library of Medicine, brucellosis is one of the most prevalent zoonotic diseases common between humans and animals.
Competitive Landscape
The major players operating in the brucellosis vaccines industry include Ceva, Colorado Serum Company, Creative Biolabs, CZ Vaccines, Fivet Animal Health, Hester Biosciences Limited, Indian Immunologicals Ltd., Jordan Bio-industries Center, Laboratories Tornel, and Merck & Co., Inc. Other players in the Brucellosis Vaccines market include VETAL Animal Health Products Inc and Veterinary Technologies Corporation.
Recent Development in the Brucellosis Vaccines Industry
- In April 2022, Ceva Santé Animale entered a joint venture with Mitsui & Co. Ltd to accelerate the expansion of the veterinary laboratory to Japan.
Key Sources Referred
- National Library of Medicine
- Biotechnology and Biological Sciences Research Council
- U.S. Department of Agriculture (USDA)
- U.S. Department of Agriculture, Foreign Agricultural Services
- World Cancer Research Fund Organization
- Ministry of Fisheries, Animal Husbandry & Dairying (India)
- Centers for Disease Control and Prevention
- University of Florida
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the brucellosis vaccines market analysis from 2024 to 2033 to identify the prevailing brucellosis vaccines market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the brucellosis vaccines market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global brucellosis vaccines market trends, key players, market segments, application areas, and market growth strategies.
Brucellosis Vaccines Market , by Type Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 0.4 Billion |
 Growth Rate | CAGR of 6.4% |
 Forecast period | 2024 - 2033 |
 Report Pages | 280 |
 By Type |
|
 By Vaccine |
|
 By Animal Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Colorado Serum Company, CZ Vaccines, Fivet Animal Health, Jordan Bio-industries Center, Creative Biolabs, Merck & Co., Inc., Ceva Poultry, Laboratories Tornel, Indian Immunologicals Ltd, Hester Biosciences Limited |
The global brucellosis vaccines market was valued at $0.2 billion in 2023.
The market value of Brucellosis Vaccines Market is projected to reach $0.4 billion by 2033
The forecast period for Brucellosis Vaccines Market is 2024-2033.
The base year is 2023 in Brucellosis Vaccines Market
Major key players that operate in the Brucellosis Vaccines Market are Colorado Serum Company, Creative Biolabs, CZ Vaccines, and Fivet Animal Health.
Loading Table Of Content...
